CNS Pharmaceuticals, Inc. Accounts Payable
CNS Pharmaceuticals, Inc. (CNSP) had Accounts Payable of $3.57 million as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2023-08-14
- 2023-06-30: Accounts Payable, Current $3.57M.
- 2023-03-31: Accounts Payable, Current $2.78M.
- 2022-12-31: Accounts Payable, Current $3.68M.
- 2022-09-30: Accounts Payable, Current $1.01M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2023-06-30 | $3.57M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.78M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $3.68M 10-Q · filed 2023-08-14 | |
| 2022-09-30 | $1.01M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $490.89K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $489.72K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.98M 10-K · filed 2023-03-31 | $1.52M 10-K · filed 2022-03-03 |
| 2021-09-30 | $1.46M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $892.49K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.06M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $946.33K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $250.18K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $150.51K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $141.25K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $243.67K 10-K · filed 2021-02-12 | |
| 2019-09-30 | $278.34K 10-Q · filed 2019-12-20 | |
| 2018-12-31 | $128.07K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |